Frank Trudo

1.7k total citations · 1 hit paper
50 papers, 1.1k citations indexed

About

Frank Trudo is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Frank Trudo has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Physiology, 39 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Frank Trudo's work include Asthma and respiratory diseases (46 papers), Respiratory and Cough-Related Research (24 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers). Frank Trudo is often cited by papers focused on Asthma and respiratory diseases (46 papers), Respiratory and Cough-Related Research (24 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers). Frank Trudo collaborates with scholars based in United States, United Kingdom and Sweden. Frank Trudo's co-authors include Trung N. Tran, David Price, Jaco Voorham, Joanna Ling, Marjan Kerkhof, Xiao Xu, Bradley E. Chipps, Christopher S. Ambrose, Ian Hirsch and Paul Newbold and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and Respiratory Medicine.

In The Last Decade

Frank Trudo

44 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study

2018 303 citations Frank Trudo, Trung N. Tran et al. Journal of Asthma and Allergy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Trudo United States	16	938	819	183	147	108	50	1.1k
Mark Forshag United States	12	454 0.5×	411 0.5×	79 0.4×	125 0.9×	67 0.6×	16	604
Robert G. Price United Kingdom	15	1.1k 1.2×	875 1.1×	311 1.7×	283 1.9×	224 2.1×	62	1.3k
Santi Nolasco Italy	16	411 0.4×	382 0.5×	136 0.7×	82 0.6×	75 0.7×	32	554
Ebymar Arismendi Spain	12	245 0.3×	250 0.3×	28 0.2×	86 0.6×	64 0.6×	43	482
Jennifer A. Namazy United States	14	295 0.3×	155 0.2×	135 0.7×	265 1.8×	232 2.1×	41	838
Ryan Dunn United States	6	235 0.3×	250 0.3×	39 0.2×	75 0.5×	53 0.5×	11	418
Jehanna Peerzada United States	5	228 0.2×	254 0.3×	40 0.2×	46 0.3×	196 1.8×	6	681
Sanjay Ramakrishnan United Kingdom	9	229 0.2×	227 0.3×	21 0.1×	26 0.2×	32 0.3×	24	379
Manon Belhassen France	13	191 0.2×	253 0.3×	46 0.3×	46 0.3×	15 0.1×	70	521
Jan Holt Norway	10	141 0.2×	94 0.1×	95 0.5×	14 0.1×	83 0.8×	22	428

Countries citing papers authored by Frank Trudo

Since Specialization

Citations

This map shows the geographic impact of Frank Trudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Trudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Trudo more than expected).

Fields of papers citing papers by Frank Trudo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Trudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Trudo. The network helps show where Frank Trudo may publish in the future.

Co-authorship network of co-authors of Frank Trudo

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Trudo. A scholar is included among the top collaborators of Frank Trudo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Trudo. Frank Trudo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilbert, Ileen, et al.. (2025). Evaluation of a disease-state education program in asthma: Application of the Knowledge-to-Action Framework. Allergy and Asthma Proceedings. 46(2). 126–134.

Papi, Alberto, Richard Beasley, Elliot Israel, et al.. (2024). Albuterol-budesonide rescue reduces progression from asthma deterioration to severe exacerbation. The Journal of Allergy and Clinical Immunology In Practice. 12(10). 2847–2851.

Chipps, Bradley E., Njira Lugogo, Warner Carr, et al.. (2024). On-treatment clinical remission of severe asthma with real-world longer-term biologic use. Journal of Allergy and Clinical Immunology Global. 4(1). 100365–100365.

Panettieri, Reynold A., Dennis K. Ledford, Bradley E. Chipps, et al.. (2022). Biologic use and outcomes among adults with severe asthma treated by US subspecialists. Annals of Allergy Asthma & Immunology. 129(4). 467–474.e3. 14 indexed citations

Lugogo, Njira, Bradley E. Chipps, Reynold A. Panettieri, Frank Trudo, & Christopher S. Ambrose. (2022). Long-Term Use of Maintenance Systemic Corticosteroids is Associated with Multiple Adverse Conditions in a Large, Real-World Cohort of US Adults with Severe Asthma. Journal of Asthma and Allergy. Volume 15. 1753–1761. 3 indexed citations

Trevor, Jennifer, Njira Lugogo, Warner Carr, et al.. (2021). Severe asthma exacerbations in the United States:. Annals of Allergy Asthma & Immunology. 127(5). 579–587.e1. 25 indexed citations

Soong, Weily, Bradley E. Chipps, Sean O’Quinn, et al.. (2021). Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma. Journal of Asthma and Allergy. Volume 14. 713–725. 16 indexed citations

Ferguson, Gary T., Tor Skärby, Lars H. Nordenmark, et al.. (2020). Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study. International Journal of COPD. Volume 15. 3123–3134. 3 indexed citations

Ambrose, Christopher S., Bradley E. Chipps, Wendy C. Moore, et al.. (2020). The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results. PubMed. Volume 11. 77–90. 16 indexed citations

10.

Hegewald, Matthew, Benjamin D. Horne, Frank Trudo, et al.. (2020). Blood Eosinophil Count and Hospital Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 15. 2629–2641. 18 indexed citations

11.

Trudo, Frank, et al.. (2019). Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials. Pneumologie. 73. 10 indexed citations

12.

Chipps, Bradley E., Ian Hirsch, Frank Trudo, Marianna Alacqua, & James Zangrilli. (2019). Benralizumab efficacy for patients with fixed airflow obstruction and severe, uncontrolled eosinophilic asthma. Annals of Allergy Asthma & Immunology. 124(1). 79–86. 29 indexed citations

13.

Soong, Weily, Warner Carr, Bradley E. Chipps, et al.. (2019). Demographic Characteristics, Comorbidities, and Exacerbation Frequency Among Patients Enrolled in the Chronicle Study: A Real-World, Prospective, Observational Study of US, Subspecialist-Treated Adults with Severe Asthma. Journal of Allergy and Clinical Immunology. 143(2). AB429–AB429. 1 indexed citations

14.

Menzies‐Gow, Andrew, Mona Bafadhel, William W. Busse, et al.. (2019). An expert consensus framework for asthma remission as a treatment goal. Journal of Allergy and Clinical Immunology. 145(3). 757–765. 225 indexed citations

15.

Chupp, Geoffrey, Njira Lugogo, Joel N. Kline, et al.. (2019). Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma. Annals of Allergy Asthma & Immunology. 122(5). 478–485. 12 indexed citations

16.

Ferguson, Gary T., Donald P. Tashkin, Tor Skärby, et al.. (2017). Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study. Respiratory Medicine. 132. 31–41. 37 indexed citations

17.

Kern, David M., Jill Davis, Setareh A. Williams, et al.. (2015). Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study. Respiratory Research. 16(1). 52–52. 26 indexed citations

18.

Murphy, Kevin R., et al.. (2015). Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI. Respiratory Medicine. 109(2). 170–179. 7 indexed citations

19.

Kern, David M., Frank Trudo, Setareh A. Williams, et al.. (2015). Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments. International Journal of COPD. 10. 2055–2055. 15 indexed citations

20.

Tunceli, Ozgur, Setareh A. Williams, David M. Kern, et al.. (2014). Comparative Effectiveness of Budesonide-Formoterol Combination and Fluticasone-Salmeterol Combination for Asthma Management: A United States Retrospective Database Analysis. The Journal of Allergy and Clinical Immunology In Practice. 2(6). 719–726.e6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact